News tagged brand-name-generic
DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions
Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances that are missing information required by law, Drug Enforcement Administration provides guidance for pharmacists regarding allowed changes or additions to such prescriptions.
Read More →Nominations for 2014 NABP Annual Awards Now Being Accepted
NABP invites you to nominate a colleague or board of pharmacy for a 2014 NABP award.
Read More →New Jersey News: New Labeling Requirement for Generic Drugs
Reprinted from the October 2009 New Jersey Board of Pharmacy Newsletter. Senate Bill 906 was signed into law on July 31, 2009, and becomes effective January 27, 2010. Section 10 of P.L.1977, c.240 (C.24:6E-9) was amended to read as follows:...
Read More →Louisiana News: Generic Substitution Procedures
Are You Sure You Know the Law? (09-04-319) Published in the April 2009 Louisiana Board of Pharmacy Newsletter We continue to receive a number of complaints against pharmacists alleging improper generic substitution. In particular, some of these complaints involve documented...
Read More →Delaware News: Substitution
Published in the September 2008 Delaware State Board of Pharmacy Newsletter Food and Drug Administration (FDA) approval for any drug product addresses quality concerns for the manufacturing process of that particular medication. Whether a product can be used as a...
Read More →Ohio News: Recent Legislation Affecting Pharmacy Practice
Published in the August 2007 Ohio State Board of Pharmacy Newsletter The Ohio General Assembly has passed, and the governor has signed, some bills that will have an impact on the practice of pharmacy in Ohio. In addition, the General...
Read More →Nevada News: Generic Substitution
Reprinted from the April 2007 Nevada State Board of Pharmacy Newsletter. The subject of generic substitution seems to arise repeatedly in one form or another. With the emergence of the now infamous “$4 generic” the scenario goes as follows: Your...
Read More →Oklahoma News: From the Inspectors
Published in the October 2006 Oklahoma State Board of Pharmacy Newsletter Pseudoephedrine (PSE) Training: As of September 30, 2006, retailers must train their employees on the new PSE restrictions using Drug Enforcement Administration (DEA) materials. Go to www.deadiversion.usdoj.gov/meth/trg_retail_081106.pdf. Reporting PSE...
Read More →Ohio News: A Generic Equivalent May be a Brand Name Drug
Published in the August 2006 Ohio State Board of Pharmacy Newsletter Frequently, pharmacists or patients call with questions about substitution on a prescription. A common misconception is that the “generic” must be a product with no brand name attached to...
Read More →North Carolina News: Item 2104 - New Labeling Law
Reprinted from the January 2006 North Carolina Board of Pharmacy Newsletter. This is another reminder that beginning in January 2006 Board rules now require the generic name of the product on the label even if no generic product is available....
Read More →